Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2013-04-20

Original market date: See footnote 1

1950-12-31

Product name:

NEO-LARYNGOBIS

DIN:

00065927 Electronic product monograph is not available

Company: 

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada  M1B 2K9

Class: 

Human

Dosage form(s):

Suppository

Route(s) of administration:

Rectal

Number of active ingredient(s):

1

Schedule(s):

OTC  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

52:92.00   EENT DRUGS, MISCELLANEOUS

Anatomical Therapeutic Chemical (ATC): See footnote 4

R02AA20  VARIOUS

Active ingredient group (AIG) number:See footnote 5

0108681002

List of active ingredient(s)
Active ingredient(s) Strength
BISMUTH DIPROPYLACETATE 135 MG

Application information

Related information

Contact us

Version 3.8.0
Date modified: